Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases

Details for Australian Patent Application No. 2008258486 (hide)

Owner Novartis AG

Inventors Pissot Soldermann, Carole; Gaul, Christoph; Holzer, Philipp; Furet, Pascal; Vangrevelinghe, Eric; Gerspacher, Marc

Agent Davies Collison Cave

Pub. Number AU-B-2008258486

PCT Pub. Number WO2008/148867

Priority 07150266.0 20.12.07 EP; 07109880.0 08.06.07 EP

Filing date 6 June 2008

Wipo publication date 11 December 2008

Acceptance publication date 10 November 2011

International Classifications

C07D 241/42 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/148867 Priority application(s): WO2008/148867

10 November 2011 Application Accepted

  Published as AU-B-2008258486

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258487-Piperidine/piperazine derivatives

2008258484